Small intestine cancer laboratory findings

Revision as of 16:24, 22 January 2019 by Anmol Pitliya (talk | contribs)
Jump to navigation Jump to search

Small intestine cancer Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Small intestine cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Small intestine cancer laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Small intestine cancer laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Small intestine cancer laboratory findings

CDC on Small intestine cancer laboratory findings

Small intestine cancer laboratory findings in the news

Blogs on Small intestine cancer laboratory findings

Directions to Hospitals Treating Small intestine cancer

Risk calculators and risk factors for Small intestine cancer laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Parminder Dhingra, M.D. [3]

Overview

Some patients with small intestine cancer may have elevated concentration of liver enzymes, which is usually suggestive of possible spread to the liver or blockage of the bile duct.

Laboratory Findings

Laboratory findings in patients with small intestine cancer include:[1]

References

  1. Zhu L, Kim K, Domenico DR, Appert HE, Howard JM (February 1996). "Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA". J Surg Oncol. 61 (2): 100–5. doi:10.1002/(SICI)1096-9098(199602)61:2<100::AID-JSO3>3.0.CO;2-G. PMID 8606540.